Ryan Mendy, Head of Account Management at Zeus Capital interviews OnTheMarket plc (LON:OTMP) CEO Ian Springett. In this, the 2nd of a three part interview, and having been listed now ...

Ryan Mendy, Head of Account Management at Zeus Capital interviews OnTheMarket plc (LON:OTMP) CEO Ian Springett. In this, the 1st of a three part interview, and now with three main ...

Zeus Capital, the independent investment banking boutique, announces senior appointments in Corporate Finance in London assisting its strategic aim of becoming the UK mid-market leader. Following the continuing success of the ...

Zeus Capital acted as Financial Adviser to Connex Solutions in the £9.1m share sale to Belerion Capital in the Manchester based technology firm. The multimillion-pound transaction fully exits three founding ...

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval ...

Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the ...

Ceres Power Holdings plc (LON:CWR) CEO Phil Caldwell chats with DirectorsTalk about it’s latest trading update. Phil talks about the last 6 months, opportunities for the company, the effects of ...

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth ...

Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for ...

City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before ...